Platinum-based Chemotherapy Plus Cetuximab for the First-line Treatment of Japanese Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of a Phase II Trial

OBJECTIVE: To assess the efficacy and safety of cetuximab in combination with cisplatin and 5-fluorouracil for first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. METHODS: In this open-label, single-arm, multicenter, Phase II study...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshino, Takayuki, Hasegawa, Yasuhisa, Takahashi, Shunji, Monden, Nobuya, Homma, Akihiro, Okami, Kenji, Onozawa, Yusuke, Fujii, Masato, Taguchi, Takahide, de Blas, Barbara, Beier, Frank, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638634/
https://www.ncbi.nlm.nih.gov/pubmed/23479384
http://dx.doi.org/10.1093/jjco/hyt034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638634/
https://www.ncbi.nlm.nih.gov/pubmed/23479384
http://dx.doi.org/10.1093/jjco/hyt034

Ejemplares similares